A clinical care program to evaluate and support individualized treatment in patients with hereditary angioedema (HAE-C1-INH)

被引：0
|
作者：
Saguer, Martinez, I [1 ]
Escuriola-Ettingshausen, C. [1 ]
Gutowski, Z. [1 ]
Linde, R. [1 ]
机构：
[1] Haemophilia Ctr Rhine Main, Morfelden Walldorf, Germany
来源：
ALLERGY | 2017年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
1303
引用
收藏
页码：709 / 709
页数：1
相关论文
共 50 条
  • [31] Dose justification for recombinant human C1INH for the treatment of acute angioedema attacks in patients with hereditary angioedema
    Relan, A.
    Haase, G.
    Hack, E.
    Nuijens, J.
    Giannetti, B.
    Pijpstra, R.
    ALLERGY, 2010, 65 : 445 - 446
  • [32] The need for individually tailored prophylaxis with C1-INH concentrate in pediatric patients with hereditary angioedema (HAE) - real life data
    Martinez Saguer, I
    Escuriola Ettingshausen, C.
    Gutowski, Z.
    Linde, R.
    ALLERGY, 2019, 74 : 753 - 753
  • [33] Treatment patterns among patients with HAE-C1-INH: Interim analysis findings from US and Canada participants in the EMPOWER study
    Goodyear, Dawn
    Lumry, William
    Anderson, John
    Gagnon, Remi
    Brouwer, Emily
    Andriotti, Tomas
    Fei, Kezhen
    Tachdjian, Raffi
    Yegin, Ashley
    Craig, Timothy
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) : AB167 - AB167
  • [34] A clinical study on pharmacokinetics of pasteurized C1-inhibitor concentrate in patients with hereditary angioedema (HAE).
    Martinez-Saguer, I
    Müller, W
    Salem, H
    Escuriola-Ettingshausen, C
    Klarmann, D
    Kreuz, W
    BLOOD, 2000, 96 (11) : 642A - +
  • [35] Understanding the Mechanism of the Disproportionately Reduced C1-Esterase Inhibitor (C1-INH) Levels in Hereditary Angioedema (HAE)
    Ren, Zhen
    Li, Tiandao
    Atkinson, John
    Wedner, H. James
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB137 - AB137
  • [36] Asymptomatic bacteruria increases the risk of edematous attacks in patients with hereditary angioedema due to C1 inhibitor deficency (C1-INH-HAE)
    Zotter, Z.
    Varga, L.
    Imreh, E.
    Veszeli, N.
    Kohalmi, K., V
    Kovacs, G.
    Nallbani, M.
    Farkas, H.
    ALLERGY, 2016, 71 : 553 - 553
  • [37] Clinical experiences with Icatibant in patients with hereditary and acquired angioedema due to C1-INH-deficiency
    Magerl, M.
    Weller, K.
    Krause, K.
    Metz, M.
    Maurer, M.
    ALLERGY, 2010, 65 : 446 - 446
  • [38] C1-Esterase inhibitor (C1-INH) functional activity of subcutaneous C1-INH for the prevention of Hereditary Angioedema (HAE) attacks: Pharmacokinetic comparison in adolescent and adult patients
    Christiansen, S.
    Zuraw, B.
    Feuersenger, H.
    Pragst, I
    Pawaskar, D.
    ALLERGY, 2018, 73 : 613 - 614
  • [39] Health-related quality of life in adult patients with hereditary angioedema due to C1 inhibitor deficiency (HAE-C1-INH) assessed by SF-36v2: preliminary results of an international study
    Caballero, T.
    Caminoa, M.
    Prior, N.
    Gomez-Traseira, C.
    Perez, E.
    Forjaz, M.
    DV-IHAE-QoL, G.
    ALLERGY, 2011, 66 : 685 - 686
  • [40] Clinical value of the treatment with rhC1INH of patients with hereditary angioedema suffering from an acute peripheral angioedema attack
    Pijpstra, R.
    Relan, A.
    Haase, G.
    Kusuma, A.
    Cicardi, M.
    Hack, E.
    Giannetti, B.
    Knulst, A.
    Moldovan, D.
    ALLERGY, 2010, 65 : 444 - 445
12345